Retina Consultants of America Sold to Cencora for Up to $5.1 Billion

Cencora, a prominent healthcare company publicly listed on the NYSE under the ticker symbol COR, has announced the acquisition of Retina Consultants of America (RCA) for approximately $4.6 billion in cash, along with an additional contingent payment of up to $500 million based on the fulfillment of specific business milestones. This transaction highlights the ongoing consolidation within the healthcare sector as companies seek to enhance their service offerings and geographical reach. RCA, recognized for its network of leading retina surgeons and specialists, provides advanced care for complex eye conditions. The seller, Webster Equity Partners, a private equity firm with a strategic focus on growth within purpose-driven healthcare organizations, sees this transaction as aligned with its mission of optimizing returns while contributing to the greater good within communities. The deal, which is subject to regulatory approval and standard closing conditions, was advised by the law firm Goodwin, with a team led by Peter Hanoian, Chris Wilson, and C.J. Murray.